Jagoda Maternia
Research Subjects
Jagoda Maternia has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Blok
The Independent Public Healthcare Institution in Przeworsk, Przeworsk, Poland
9 shared publications - Aleksandra Łoś
College of Medical Sciences, University of Rzeszów, Poland
9 shared publications - Dominik Wiater
University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland
9 shared publications - Gabriela Płodzień
Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland
9 shared publications - Kacper Szkodziński
University Clinical Hospital F. Chopin in Rzeszów, Rzeszów, Poland
9 shared publications - Karolina Majowicz-Czaszyńska
Saint Queen Jadwiga Clinical Regional Hospital in Rzeszów, Rzeszów, Poland
9 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
MODERN APPROACHES TO OBESITY TREATMENT WITH CONSIDERATION OF PHARMACOTHERAPY AND DIET THERAPY
Obesity represents one of the most significant public health challenges worldwide, serving as a key risk factor for numerous chronic diseases, including type 2 diabetes and cardiovascular diseases. The aim of this article was to present modern approaches to obesity management, with particular emphasis on the role of health behaviors, diet therapy, dietary catering services, and semaglutide-based pharmacotherapy. This paper reviews issues related to the concept of health and health behaviors, principles of proper nutrition, and selected dietary models used in obesity treatment. Special attention was paid to dietary catering as a modern tool supporting the implementation of nutritional recommendations, as well as pharmacotherapy utilizing GLP-1 receptor agonists. The conducted analysis indicates that effective obesity treatment requires a comprehensive and interdisciplinary approach, combining lifestyle modification, appropriately tailored diet therapy, and pharmacological support. Modern solutions, such as personalized nutrition and the use of semaglutide-based medications, can significantly increase treatment efficacy and promote long-term weight reduction.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessMODERN APPROACHES TO OBESITY TREATMENT WITH CONSIDERATION OF PHARMACOTHERAPY AND DIET THERAPY
Obesity represents one of the most significant public health challenges worldwide, serving as a key risk factor for numerous chronic diseases, including type 2 diabetes and cardiovascular diseases. The aim of this article was to present modern approaches to obesity management, with particular emphasis on the role of health behaviors, diet therapy, dietary catering services, and semaglutide-based pharmacotherapy. This paper reviews issues related to the concept of health and health behaviors, principles of proper nutrition, and selected dietary models used in obesity treatment. Special attention was paid to dietary catering as a modern tool supporting the implementation of nutritional recommendations, as well as pharmacotherapy utilizing GLP-1 receptor agonists. The conducted analysis indicates that effective obesity treatment requires a comprehensive and interdisciplinary approach, combining lifestyle modification, appropriately tailored diet therapy, and pharmacological support. Modern solutions, such as personalized nutrition and the use of semaglutide-based medications, can significantly increase treatment efficacy and promote long-term weight reduction.
- Open Access
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
GUT MICROBIOTA AND RECURRENT UPPER RESPIRATORY TRACT INFECTIONS: EMERGING IMPLICATIONS FOR OTOLARYNGOLOGY
Recurrent upper respiratory tract infections (URTIs) represent a significant clinical challenge in otolaryngology, with growing evidence suggesting that intestinal microbiota may play an important role in their pathogenesis. The gut-lung axis describes bidirectional immunological, metabolic, and microbial communication between the gastrointestinal and respiratory systems. Disturbances in gut microbiota composition, known as dysbiosis, can impair mucosal immunity through altered IgA production, reduced regulatory T‑cell activity, and decreased levels of immunomodulatory metabolites such as short‑chain fatty acids. These changes may increase susceptibility to infections of the pharynx, sinuses, and middle ear, contributing to their chronic and recurrent course. Frequent antibiotic use, common in ENT practice, may further exacerbate dysbiosis, creating a potential vicious cycle of recurrent infections. Emerging therapeutic strategies - such as probiotics, prebiotics, dietary interventions, and personalized microbiome‑based approaches - offer promising but yet insufficiently validated avenues for supporting standard treatment. Further prospective clinical studies are required to better define the role of the gut-lung axis in the development and management of recurrent ENT infections and to assess the effectiveness of microbiome‑modulating therapies.
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessGUT MICROBIOTA AND RECURRENT UPPER RESPIRATORY TRACT INFECTIONS: EMERGING IMPLICATIONS FOR OTOLARYNGOLOGY
Recurrent upper respiratory tract infections (URTIs) represent a significant clinical challenge in otolaryngology, with growing evidence suggesting that intestinal microbiota may play an important role in their pathogenesis. The gut-lung axis describes bidirectional immunological, metabolic, and microbial communication between the gastrointestinal and respiratory systems. Disturbances in gut microbiota composition, known as dysbiosis, can impair mucosal immunity through altered IgA production, reduced regulatory T‑cell activity, and decreased levels of immunomodulatory metabolites such as short‑chain fatty acids. These changes may increase susceptibility to infections of the pharynx, sinuses, and middle ear, contributing to their chronic and recurrent course. Frequent antibiotic use, common in ENT practice, may further exacerbate dysbiosis, creating a potential vicious cycle of recurrent infections. Emerging therapeutic strategies - such as probiotics, prebiotics, dietary interventions, and personalized microbiome‑based approaches - offer promising but yet insufficiently validated avenues for supporting standard treatment. Further prospective clinical studies are required to better define the role of the gut-lung axis in the development and management of recurrent ENT infections and to assess the effectiveness of microbiome‑modulating therapies.
- Open Access
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
APPLICATION OF ARTIFICIAL INTELLIGENCE IN INTENSIVE CARE: CLINICAL POTENTIAL AND CHALLENGES
Background: Contemporary intensive care units (ICUs) generate vast amounts of real-time data, leading to staff cognitive overload and the phenomenon of alarm fatigue. Traditional prognostic scoring systems (APACHE II, SOFA) are inherently static and fail to account for dynamic clinical trends. Artificial intelligence (AI) algorithms, including machine learning (ML) and deep learning (DL), offer novel capabilities for continuous monitoring and early prediction of life-threatening conditions. Objective: To analyze the clinical potential and implementation challenges associated with the deployment of AI algorithms in intensive care settings. Methods: A comprehensive literature review was conducted across the PubMed, Embase, and IEEE Xplore databases for the years 2018–2026, focusing on studies utilizing multicenter databases (such as MIMIC-IV and eICU). Results: AI algorithms demonstrate high discriminative performance (AUROC 0.79–0.96) in the early detection of sepsis, prediction of hemodynamic instability with a 5-to-15-minute lead time, and dynamic mortality risk estimation. In the context of mechanical ventilation, deep learning models (specifically convolutional neural networks, CNNs) enable automated detection of patient-ventilator asynchrony with an accuracy exceeding 90%, as well as precise forecasting of extubation success. Conclusions: Artificial intelligence holds immense potential for optimizing ICU patient care. However, primary implementation barriers persist, including the lack of model interpretability (the "black box" problem), domain shift, and ethico-psychological dilemmas, such as clinician moral distress and the risk of care dehumanization. AI systems should function strictly as clinical decision support tools under physician supervision.
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessAPPLICATION OF ARTIFICIAL INTELLIGENCE IN INTENSIVE CARE: CLINICAL POTENTIAL AND CHALLENGES
Background: Contemporary intensive care units (ICUs) generate vast amounts of real-time data, leading to staff cognitive overload and the phenomenon of alarm fatigue. Traditional prognostic scoring systems (APACHE II, SOFA) are inherently static and fail to account for dynamic clinical trends. Artificial intelligence (AI) algorithms, including machine learning (ML) and deep learning (DL), offer novel capabilities for continuous monitoring and early prediction of life-threatening conditions. Objective: To analyze the clinical potential and implementation challenges associated with the deployment of AI algorithms in intensive care settings. Methods: A comprehensive literature review was conducted across the PubMed, Embase, and IEEE Xplore databases for the years 2018–2026, focusing on studies utilizing multicenter databases (such as MIMIC-IV and eICU). Results: AI algorithms demonstrate high discriminative performance (AUROC 0.79–0.96) in the early detection of sepsis, prediction of hemodynamic instability with a 5-to-15-minute lead time, and dynamic mortality risk estimation. In the context of mechanical ventilation, deep learning models (specifically convolutional neural networks, CNNs) enable automated detection of patient-ventilator asynchrony with an accuracy exceeding 90%, as well as precise forecasting of extubation success. Conclusions: Artificial intelligence holds immense potential for optimizing ICU patient care. However, primary implementation barriers persist, including the lack of model interpretability (the "black box" problem), domain shift, and ethico-psychological dilemmas, such as clinician moral distress and the risk of care dehumanization. AI systems should function strictly as clinical decision support tools under physician supervision.
- Open Access
- 15 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
ADJUVANT THERAPY IN MELANOMA: A REVIEW OF CONTEMPORARY TREATMENT STRATEGIES
Melanoma is a highly aggressive skin cancer with a steadily increasing annual incidence. Although it accounts for only 1% of diagnosed skin cancers, it has the highest mortality rate among them. Therefore, it is essential to continuously develop treatment methods and improve long-term outcomes. In recent years, a breakthrough has been the introduction of adjuvant therapy following surgical treatment, which has become the standard of treatment. This has led to an increase in recurrence-free survival and overall survival in high-risk patients. Immunotherapy with anti-CTLA-4 and anti-PD-1 antibodies, as well as targeted therapy for patients with BRAF mutations, have become part of the standard of care. These are recommended for patients with stage IIB–IV melanoma at high risk of recurrence to eliminate micrometastases. Various treatment regimens targeting different patient subgroups are still being investigated to optimize outcomes and minimize adverse effects. This paper reviews and discusses current adjuvant treatment strategies for melanoma. In addition, it highlights the emerging role and future potential of these therapies in the neoadjuvant setting.
- 15 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessADJUVANT THERAPY IN MELANOMA: A REVIEW OF CONTEMPORARY TREATMENT STRATEGIES
Melanoma is a highly aggressive skin cancer with a steadily increasing annual incidence. Although it accounts for only 1% of diagnosed skin cancers, it has the highest mortality rate among them. Therefore, it is essential to continuously develop treatment methods and improve long-term outcomes. In recent years, a breakthrough has been the introduction of adjuvant therapy following surgical treatment, which has become the standard of treatment. This has led to an increase in recurrence-free survival and overall survival in high-risk patients. Immunotherapy with anti-CTLA-4 and anti-PD-1 antibodies, as well as targeted therapy for patients with BRAF mutations, have become part of the standard of care. These are recommended for patients with stage IIB–IV melanoma at high risk of recurrence to eliminate micrometastases. Various treatment regimens targeting different patient subgroups are still being investigated to optimize outcomes and minimize adverse effects. This paper reviews and discusses current adjuvant treatment strategies for melanoma. In addition, it highlights the emerging role and future potential of these therapies in the neoadjuvant setting.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
TYPE 2 DIABETES MELLITUS: PATHOPHYSIOLOGY, DIAGNOSTICS, AND CONTEMPORARY THERAPEUTIC STRATEGIES. A REVIEW
Type 2 diabetes mellitus (T2DM) remains one of the dominant clinical challenges in modern medicine. According to the 11th edition of the IDF Diabetes Atlas (2025), 589 million adults currently suffer from this condition, and it is estimated that by 2050, the number of patients will increase by 46%, reaching 853 million. This paper reviews current knowledge on the pathogenesis of T2DM, which includes peripheral insulin resistance, the progressive loss of pancreatic beta-cell mass alongside secondary impairment of their secretory function, and systemic inflammation. Diagnostic criteria are presented in accordance with the 2025 PTD (Diabetes Poland) guidelines, including recommendations for screening and the identification of high-risk groups. A fundamental part of the study is devoted to modern pharmacotherapy, with a particular focus on SGLT-2 inhibitors and GLP-1 receptor agonists as drugs with documented cardioneproprotective effects. Furthermore, the role of metabolic surgery and the importance of comprehensive, multidisciplinary care in the prevention and treatment of organ-related complications are discussed.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessTYPE 2 DIABETES MELLITUS: PATHOPHYSIOLOGY, DIAGNOSTICS, AND CONTEMPORARY THERAPEUTIC STRATEGIES. A REVIEW
Type 2 diabetes mellitus (T2DM) remains one of the dominant clinical challenges in modern medicine. According to the 11th edition of the IDF Diabetes Atlas (2025), 589 million adults currently suffer from this condition, and it is estimated that by 2050, the number of patients will increase by 46%, reaching 853 million. This paper reviews current knowledge on the pathogenesis of T2DM, which includes peripheral insulin resistance, the progressive loss of pancreatic beta-cell mass alongside secondary impairment of their secretory function, and systemic inflammation. Diagnostic criteria are presented in accordance with the 2025 PTD (Diabetes Poland) guidelines, including recommendations for screening and the identification of high-risk groups. A fundamental part of the study is devoted to modern pharmacotherapy, with a particular focus on SGLT-2 inhibitors and GLP-1 receptor agonists as drugs with documented cardioneproprotective effects. Furthermore, the role of metabolic surgery and the importance of comprehensive, multidisciplinary care in the prevention and treatment of organ-related complications are discussed.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
EMOTIONAL STATE OF PREGNANT WOMEN: PSYCHOGENIC AND CLINICAL FACTORS, TREATMENT OPTIONS, AND PREDICTION USING ARTIFICIAL INTELLIGENCE – A NARRATIVE REVIEW
The aim of this study is to analyze the psychogenic and clinical factors influencing the emotional state of women during pregnancy and to discuss the possibilities for the treatment and prediction of mental disorders using artificial intelligence (AI). The article presents the physiological and psychosocial determinants of emotional functioning in pregnant women, with particular emphasis on risk factors for mood disorders, such as depression and anxiety. Contemporary therapeutic approaches utilized in the perinatal period are discussed, encompassing both medical methods and non-medical forms of psychological support. Special attention is devoted to the role of modern technologies—including machine learning algorithms, mobile applications, and chatbots—in the process of early disorder detection and mental health support for pregnant women. Furthermore, the significance of diagnostic tools, such as ultrasonography (USG) and cardiotocography (CTG), in monitoring fetal well-being is addressed, alongside their potential integration with AI-based systems. The literature review indicates that AI can serve as a significant supplement to traditional medical care, contributing to improved diagnostic quality, enhanced predictive capabilities and increased accessibility of support for pregnant women.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessEMOTIONAL STATE OF PREGNANT WOMEN: PSYCHOGENIC AND CLINICAL FACTORS, TREATMENT OPTIONS, AND PREDICTION USING ARTIFICIAL INTELLIGENCE – A NARRATIVE REVIEW
The aim of this study is to analyze the psychogenic and clinical factors influencing the emotional state of women during pregnancy and to discuss the possibilities for the treatment and prediction of mental disorders using artificial intelligence (AI). The article presents the physiological and psychosocial determinants of emotional functioning in pregnant women, with particular emphasis on risk factors for mood disorders, such as depression and anxiety. Contemporary therapeutic approaches utilized in the perinatal period are discussed, encompassing both medical methods and non-medical forms of psychological support. Special attention is devoted to the role of modern technologies—including machine learning algorithms, mobile applications, and chatbots—in the process of early disorder detection and mental health support for pregnant women. Furthermore, the significance of diagnostic tools, such as ultrasonography (USG) and cardiotocography (CTG), in monitoring fetal well-being is addressed, alongside their potential integration with AI-based systems. The literature review indicates that AI can serve as a significant supplement to traditional medical care, contributing to improved diagnostic quality, enhanced predictive capabilities and increased accessibility of support for pregnant women.
- 1 July 2026
- Published by Index Copernicus in Journal of Kinesiology and Exercise Sciences
- Vol. 36, 1-11
Doping in Sport as a Sports Medicine Problem: A Narrative Review of Global Anti-Doping Regulations and Recent Cases
Background: Doping in sport should be understood not only as a breach of fair play or a disciplinary offence, but also as an important problem of sports medicine. The use of prohibited substances and methods may interfere with physiological processes, affect treatment and recovery, increase health risks and create diagnostic, pharmacological and legal challenges for athletes and medical personnel. The aim of this narrative review was to present doping as a complex medical and regulatory phenomenon, with particular emphasis on its significance for sports medicine. Methods: A narrative review was conducted using selected scientific publications, legal acts, regulatory documents and official decisions concerning contemporary anti-doping cases. The analysis included the World Anti-Doping Code, WADA International Standards, the Prohibited List, the UNESCO International Convention against Doping in Sport, Olympic anti-doping regulations and official documents concerning selected recent cases in professional sport. Results: Contemporary doping extends beyond the intentional use of prohibited substances. It also includes prohibited methods, masking practices, manipulation of biological samples, contamination of medicines or supplements, abnormalities in the Athlete Biological Passportand the conduct of athlete support personnel. The cases of Simona Halep, Iga Świątek and Jannik Sinner illustrate that anti-doping responsibility may arise even when the athlete does not intentionally seek to gain an unfair advantage. These examples demonstrate the importance of strict liability, biological monitoring, careful pharmacological decision-making, documentation of treatment and control over the actions of support personnel. Conclusions: Doping should be treated as a multidimensional problem situated at the intersection of sports medicine, law and ethics. Medical decisions concerning athletes should take into account not only clinical indications, but also current anti-doping regulations, the possibility of therapeutic use exemption and the risk of unintentional anti-doping rule violations. Effective prevention requires cooperation between athletes, physicians, physiotherapists, coaches and anti-doping organisations.
- 1 July 2026
- Published by Index Copernicus in Journal of Kinesiology and Exercise Sciences
- Vol. 36, 1-11
Doping in Sport as a Sports Medicine Problem: A Narrative Review of Global Anti-Doping Regulations and Recent Cases
Background: Doping in sport should be understood not only as a breach of fair play or a disciplinary offence, but also as an important problem of sports medicine. The use of prohibited substances and methods may interfere with physiological processes, affect treatment and recovery, increase health risks and create diagnostic, pharmacological and legal challenges for athletes and medical personnel. The aim of this narrative review was to present doping as a complex medical and regulatory phenomenon, with particular emphasis on its significance for sports medicine. Methods: A narrative review was conducted using selected scientific publications, legal acts, regulatory documents and official decisions concerning contemporary anti-doping cases. The analysis included the World Anti-Doping Code, WADA International Standards, the Prohibited List, the UNESCO International Convention against Doping in Sport, Olympic anti-doping regulations and official documents concerning selected recent cases in professional sport. Results: Contemporary doping extends beyond the intentional use of prohibited substances. It also includes prohibited methods, masking practices, manipulation of biological samples, contamination of medicines or supplements, abnormalities in the Athlete Biological Passportand the conduct of athlete support personnel. The cases of Simona Halep, Iga Świątek and Jannik Sinner illustrate that anti-doping responsibility may arise even when the athlete does not intentionally seek to gain an unfair advantage. These examples demonstrate the importance of strict liability, biological monitoring, careful pharmacological decision-making, documentation of treatment and control over the actions of support personnel. Conclusions: Doping should be treated as a multidimensional problem situated at the intersection of sports medicine, law and ethics. Medical decisions concerning athletes should take into account not only clinical indications, but also current anti-doping regulations, the possibility of therapeutic use exemption and the risk of unintentional anti-doping rule violations. Effective prevention requires cooperation between athletes, physicians, physiotherapists, coaches and anti-doping organisations.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
PLATELET-RICH PLASMA IN DERMAL REMODELING: A PROSPECTIVE REAL-WORLD CASE SERIES INTEGRATING CLINICAL AND PATIENT-REPORTED OUTCOMES
Background: Platelet-rich plasma (PRP) is a modality recognized in the field of dermatology for its regenerative properties. However, there is significant clinical variety, particularly on patient-reported outcomes and real-world effectiveness across indications. Objective: The aim of this prospective observational case series was to evaluate the efficacy of PRP therapy in real-life clinical setting based on clinician-assessed and patient-reported outcomes. Methods: Fifty patients received autologous PRP treatment between January and June 2019. PRP was prepared using a standardized centrifugation process and applied as intradermal injections at 3-4 weeks intervals. Clinical indications included striae distensae, post-traumatic and burn scars, and skin quality concerns. Standardized clinical photography, retrospective observer-based Patient and Observer Scar Assessment Scale (POSAS) scoring, and a structured patient-reported outcome (PRO) instrument assessing perceived efficacy and satisfaction were used to evaluate outcomes. Descriptive analysis was performed, including summary statistics of PRO and POSAS score changes in representative cases. Results: The results of PRP treatment were variable, but mostly positive. The most consistent results were improvements in skin texture, skin firmness and overall appearance. Early-stage dermal injury (e.g., striae distensae) showed greater relative improvement compared with mature scars. POSAS scores decreased in representative cases, and the majority of the patients reported high satisfaction and willingness to undergo repeat treatment. No major adverse events were observed. Overall, 90% of patients expressed willingness to undergo repeat treatment, reflecting high satisfaction. Conclusions: PRP therapy demonstrated favorable outcomes in a real-life clinical setting, particularly in improving skin texture, firmness and overall skin appearance.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessPLATELET-RICH PLASMA IN DERMAL REMODELING: A PROSPECTIVE REAL-WORLD CASE SERIES INTEGRATING CLINICAL AND PATIENT-REPORTED OUTCOMES
Background: Platelet-rich plasma (PRP) is a modality recognized in the field of dermatology for its regenerative properties. However, there is significant clinical variety, particularly on patient-reported outcomes and real-world effectiveness across indications. Objective: The aim of this prospective observational case series was to evaluate the efficacy of PRP therapy in real-life clinical setting based on clinician-assessed and patient-reported outcomes. Methods: Fifty patients received autologous PRP treatment between January and June 2019. PRP was prepared using a standardized centrifugation process and applied as intradermal injections at 3-4 weeks intervals. Clinical indications included striae distensae, post-traumatic and burn scars, and skin quality concerns. Standardized clinical photography, retrospective observer-based Patient and Observer Scar Assessment Scale (POSAS) scoring, and a structured patient-reported outcome (PRO) instrument assessing perceived efficacy and satisfaction were used to evaluate outcomes. Descriptive analysis was performed, including summary statistics of PRO and POSAS score changes in representative cases. Results: The results of PRP treatment were variable, but mostly positive. The most consistent results were improvements in skin texture, skin firmness and overall appearance. Early-stage dermal injury (e.g., striae distensae) showed greater relative improvement compared with mature scars. POSAS scores decreased in representative cases, and the majority of the patients reported high satisfaction and willingness to undergo repeat treatment. No major adverse events were observed. Overall, 90% of patients expressed willingness to undergo repeat treatment, reflecting high satisfaction. Conclusions: PRP therapy demonstrated favorable outcomes in a real-life clinical setting, particularly in improving skin texture, firmness and overall skin appearance.
- Open Access
- 24 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW
Introduction: Depressive disorders are one of the greatest public health challenges worldwide, affecting up to 16% of the population over a lifetime and significantly impacting quality of life, disability, and premature mortality. Major depressive disorder (MDD) is a leading cause of disability, despite the availability of numerous treatment options. In 20–50% of patients, traditional pharmacotherapy and psychotherapy become ineffective, leading to a diagnosis of treatment-resistant depression (TRD). Objective: The objective of this study was to provide a thorough assessment of current research findings evaluating the efficacy and safety of psilocybin-assisted therapy (PAT) in patients with MDD and TRD, with particular emphasis on rapid antidepressant effects and long-term therapeutic potential. Methods: A literature review was conducted in the PubMed and Google Scholar databases. Keywords related to psilocybin, depression, treatment-resistant depression, and psychedelic-assisted therapy were used. Results: Psilocybin-assisted psychotherapy is a promising alternative for the treatment of MDD, TRD, and secondary depression. Compared to traditional antidepressants, PAT is characterized by a faster onset of action, symptom reduction often occurs as early as the first week after starting therapy, and the achieved results may persist long-term for up to 6–12 months. In addition, many patients showed improvement in anhedonia, anxiety, and overall psychosocial functioning. Conclusions: Psilocybin represents a promising therapeutic alternative for patients with severe depression and TRD, offering rapid and lasting antidepressant effects. Its use could significantly change the approach to treating depression, particularly in cases resistant to standard therapies.
- 24 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessPSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW
Introduction: Depressive disorders are one of the greatest public health challenges worldwide, affecting up to 16% of the population over a lifetime and significantly impacting quality of life, disability, and premature mortality. Major depressive disorder (MDD) is a leading cause of disability, despite the availability of numerous treatment options. In 20–50% of patients, traditional pharmacotherapy and psychotherapy become ineffective, leading to a diagnosis of treatment-resistant depression (TRD). Objective: The objective of this study was to provide a thorough assessment of current research findings evaluating the efficacy and safety of psilocybin-assisted therapy (PAT) in patients with MDD and TRD, with particular emphasis on rapid antidepressant effects and long-term therapeutic potential. Methods: A literature review was conducted in the PubMed and Google Scholar databases. Keywords related to psilocybin, depression, treatment-resistant depression, and psychedelic-assisted therapy were used. Results: Psilocybin-assisted psychotherapy is a promising alternative for the treatment of MDD, TRD, and secondary depression. Compared to traditional antidepressants, PAT is characterized by a faster onset of action, symptom reduction often occurs as early as the first week after starting therapy, and the achieved results may persist long-term for up to 6–12 months. In addition, many patients showed improvement in anhedonia, anxiety, and overall psychosocial functioning. Conclusions: Psilocybin represents a promising therapeutic alternative for patients with severe depression and TRD, offering rapid and lasting antidepressant effects. Its use could significantly change the approach to treating depression, particularly in cases resistant to standard therapies.